Nemeth, Elizabeta

In anemia of multiple myeloma, hepcidin is induced by increased bone morphogenetic protein 2

Maes, K., Nemeth, E., Roodman, G. D., Huston, A., Esteve, F., Freytes, C., Callander, N., Katodritou, E., Tussing-Humphreys, L., Rivera, S., et al. (2010) · Blood

Iron Metabolism and DisordersCytokine Signaling Pathways and Interactions

Cited by 132

Functional properties of human ferroportin, a cellular iron exporter reactive also with cobalt and zinc

Mitchell, C. J., Shawki, A., Ganz, T., Nemeth, E., & Mackenzie, B. (2014) · American Journal of Physiology-Cell Physiology

Iron Metabolism and DisordersTrace Elements in Health

Cited by 132

Hepcidin induction by pathogens and pathogen-derived molecules is strongly dependent on interleukin-6

Rodriguez, R., Jung, C.-L., Gabayan, V., Deng, J. C., Ganz, T., Nemeth, E., & Bulut, Y. (2014) · Infection and Immunity

Iron Metabolism and DisordersImmune Response and Inflammation

Cited by 127

Immunoassay for human serum erythroferrone

Ganz, T., Jung, G., Naeim, A., Ginzburg, Y., Pakbaz, Z., Walter, P. B., Kautz, L., & Nemeth, E. (2017) · Blood

Iron Metabolism and DisordersErythropoietin and Anemia Treatment

Cited by 125

Reduction of serum hepcidin by hemodialysis in pediatric and adult patients

Zaritsky, J., Young, B., Gales, B., Wang, H.-J., Rastogi, A., Westerman, M., Nemeth, E., Ganz, T., & Salusky, I. B. (2010) · Clinical Journal of the American Society of Nephrology

Iron Metabolism and DisordersErythropoietin and Anemia Treatment

Cited by 107

Decreased serum hepcidin and improved functional iron status 6 months after restrictive bariatric surgery

Tussing‐Humphreys, L. M., Nemeth, E., Fantuzzi, G., Freels, S., Holterman, A. L., Galvani, C., Ayloo, S., Vitello, J., & Braunschweig, C. (2010) · Obesity

Iron Metabolism and DisordersBariatric Surgery and Outcomes

Cited by 105

Hepcidin-mediated iron sequestration protects against bacterial dissemination during pneumonia

Michels, K. R., Zhang, Z., Bettina, A. M., Cagnina, R. E., Stefanova, D., Burdick, M. D., Vaulont, S., Nemeth, E., Ganz, T., & Mehrad, B. (2017) · JCI Insight

Iron Metabolism and DisordersFerroptosis and cancer prognosis

Cited by 93

Iron absorption in dysmetabolic iron overload syndrome is decreased and correlates with increased plasma hepcidin

Ruivard, M., Lainé, F., Ganz, T., Olbina, G., Westerman, M., Nemeth, E., Rambeau, M., Mazur, A., Gerbaud, L., Tournilhac, V., et al. (2009) · Journal of Hepatology

Iron Metabolism and DisordersNeurological diseases and metabolism

Cited by 89

Hepcidin and iron disorders: new biology and clinical approaches

Arezes, J., & Nemeth, E. (2015) · International Journal of Laboratory Hematology

Iron Metabolism and DisordersFerroptosis and cancer prognosis

Cited by 88

A variant erythroferrone disrupts iron homeostasis in SF3B1 -mutated myelodysplastic syndrome

Bondu, S., Alary, A.-S., Lefèvre, C., Houy, A., Jung, G., Lefebvre, T., Rombaut, D., Boussaid, I., Bousta, A., Guillonneau, F., et al. (2019) · Science Translational Medicine

Acute Myeloid Leukemia ResearchIron Metabolism and Disorders

Cited by 85

High-throughput screening of small molecules identifies hepcidin antagonists

Fung, E., Sugianto, P., Hsu, J., Damoiseaux, R., Ganz, T., & Nemeth, E. (2013) · Molecular Pharmacology

Iron Metabolism and DisordersFerroptosis and cancer prognosis

Cited by 78

Hepcidin Protects against Lethal Escherichia coli Sepsis in Mice Inoculated with Isolates from Septic Patients

Stefanova, D., Raychev, A., Deville, J., Humphries, R., Campeau, S., Ruchala, P., Nemeth, E., Ganz, T., & Bulut, Y. (2018) · Infection and Immunity

Iron Metabolism and DisordersSepsis Diagnosis and Treatment

Cited by 68

Iron in Lung Pathology

Zhang, V., Nemeth, E., & Kim, A. (2019) · Pharmaceuticals

Iron Metabolism and DisordersFerroptosis and cancer prognosis

Cited by 57

Calcium is an essential cofactor for metal efflux by the ferroportin transporter family

Deshpande, C. N., Ruwe, T. A., Shawki, A., Xin, V., Vieth, K. R., Valore, E. V., Qiao, B., Ganz, T., Nemeth, E., Mackenzie, B., et al. (2018) · Nature Communications

Iron Metabolism and DisordersNeurological diseases and metabolism

Cited by 57

Cellular Catabolism of the Iron-Regulatory Peptide Hormone Hepcidin

Preza, G. C., Pinon, R., Ganz, T., & Nemeth, E. (2013) · PLoS ONE

Iron Metabolism and DisordersFerroptosis and cancer prognosis

Cited by 56

Mouse Models of Anemia of Cancer

Kim, A., Rivera, S., Shprung, D., Limbrick, D., Gabayan, V., Nemeth, E., & Ganz, T. (2014) · PLoS ONE

Iron Metabolism and DisordersErythropoietin and Anemia Treatment

Cited by 35

Essential role of Hepcidin in host resistance to disseminated candidiasis

Arekar, T., Katikaneni, D., Kasem, S., Desai, D., Acharya, T., Cole, A., Khodayari, N., Vaulont, S., Hube, B., Nemeth, E., et al. (2024) · Cell Reports

Antifungal resistance and susceptibilityIron Metabolism and Disorders

Cited by 9